Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Torres Novas

12 clinical trials in Torres Novas, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Torres Novas at a glance
12
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

12 trials in Torres Novas

Open in trial search
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

IgA nephropathy

Recruiting
Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:ZIGAKIBART
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not yet recruiting
Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Regn7508
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:PortugalPortugal
  • Participants:18–64 years
  • Sponsor:Bayer AG

Obesity

Not recruiting
Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.

Atrial fibrillation

Not recruiting
Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Bay 3283142
  • Sponsor:Bayer AG
Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Atrial fibrillation+2

Not recruiting
Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Torres Novas

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on cardiovascular disease prevention and treatment, particularly investigating new therapies for patients with atrial fibrillation to prevent stroke and systemic embolism.

  • Stroke Prevention
  • Cardiac Safety Studies
  • Heart Failure Management

Advanced research comparing novel anticoagulants and evaluating cardiovascular outcomes in high-risk populations.

02 Nephrology Studies

Comprehensive research into chronic kidney disease treatments, including innovative approaches for both diabetic and non-diabetic conditions. Studies examining new therapies for IgA Nephropathy.

  • Protein Reduction Strategies
  • Kidney Disease Progression
  • Albumin Management

Trials evaluating novel compounds to delay disease progression and improve renal outcomes.

03 Metabolic Disorders

Clinical investigations targeting obesity and related metabolic conditions, with a focus on cardiovascular safety and weight management interventions.

  • Weight Management
  • Cardiovascular Risk Assessment
  • Metabolic Health

Research examining innovative treatments for obesity while monitoring cardiovascular safety parameters.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.